The relationship between nicotine use and mental health is one of the most complex and frequently misunderstood areas in addiction research. People with anxiety and depression use nicotine products at rates substantially higher than the general population — approximately twice the prevalence in some studies — and the direction of causality between nicotine use and mental health conditions has been debated in the scientific literature for decades. For vapers, this relationship matters in several practical ways: how vaping affects mood and anxiety in the short term, how nicotine dependence interacts with existing mental health conditions, and what happens to mental health when nicotine use is reduced or stopped.
The picture that emerges from the research is more nuanced than either the popular narrative that vaping relieves stress and anxiety, or the counter-narrative that nicotine causes or worsens mental health conditions. Both contain partial truths, and understanding the distinction between nicotine’s acute pharmacological effects and its long-term consequences for emotional regulation is the key to making sense of the relationship.
Nicotine’s Short-Term Effects on Mood and Anxiety
The immediate subjective effects of nicotine in a dependent user are unambiguously positive: reduced tension, improved concentration, enhanced mood, and a sense of calm that many vapers describe as the primary benefit of their habit. These effects are real and pharmacologically well-understood. Nicotine activates the mesolimbic dopamine pathway, producing a rewarding signal that temporarily improves mood. It acts on norepinephrine and serotonin signalling in ways that reduce anxiety and enhance cognitive performance in the short term.
The critical qualification is in the phrase “in a dependent user.” The apparent stress-relieving effect of vaping is not the same as a stress-relieving effect that would be available to a non-user. What regular vapers are primarily relieving when they vape in response to stress is nicotine withdrawal — the anxious, tense, irritable state produced by declining blood nicotine levels in a dependent person. The vape does not reduce stress below the level of a non-dependent baseline; it returns the vaper to a normal baseline from a withdrawal-induced deficit.
This distinction has been confirmed by research comparing stress levels in smokers and non-smokers across similar experimental stress conditions. The often-cited finding that smokers are more stressed than non-smokers reflects, at least in part, the chronic background of mild withdrawal that dependent nicotine users experience between doses rather than a pre-existing higher stress level. In other words, nicotine use may create the very stress that it appears to relieve.
The Anxiety-Nicotine Relationship: Which Comes First?
People with anxiety disorders use nicotine products at rates approximately double those of the general population, and this statistical association has driven substantial research into the direction of causality. Three hypotheses have been advanced: that pre-existing anxiety leads people to use nicotine products as self-medication; that nicotine use increases the risk of developing anxiety disorders; or that both are driven by shared underlying factors such as genetic vulnerability, trauma history, or adversity exposure.
The evidence now supports a role for all three mechanisms, with the balance varying between individuals. Longitudinal studies following young people from before nicotine use initiation through adulthood have found that those who initiate nicotine use have higher pre-existing anxiety scores than those who do not — supporting the self-medication hypothesis. The same studies have also found that nicotine initiation predicts increased anxiety in subsequent years, supporting the causation hypothesis. And twin studies have identified shared genetic factors that increase vulnerability to both anxiety and nicotine dependence simultaneously.
For vapers, the self-medication framework is the most clinically relevant: many people who vape — particularly those who started vaping rather than smoking — report that they began vaping specifically to manage anxiety or stress. This is a rational individual response to a genuine need, but it creates a dependency that then generates its own anxiety through withdrawal, potentially leaving the person in a worse position than if they had addressed the underlying anxiety through other means.
Depression and Nicotine Use: A Bidirectional Relationship
The relationship between depression and nicotine use is similarly bidirectional and complex. Smoking rates among people with major depressive disorder are approximately double those of the general population, and the same pattern is emerging in data on vaping. People with depression are more likely to use nicotine products, and nicotine use is associated with increased risk of depressive episodes — particularly in young people.
The neurobiological mechanism for the depression-nicotine connection involves the dopaminergic system that both depression and nicotine dependence directly affect. Chronic nicotine use downregulates dopamine receptor sensitivity — the brain adapts to the artificially elevated dopamine signal from nicotine by reducing receptor density and sensitivity. When nicotine is absent, as during the overnight gap for most vapers, this downregulation produces a hypodopaminergic state — a neurobiological condition associated with reduced motivation, low mood, and anhedonia that mirrors the symptoms of depression.
For people who already have depression, this cycling between nicotine-adequate states and withdrawal-associated hypodopaminergic states may amplify the mood instability associated with their condition. For people without a pre-existing depressive disorder, chronic nicotine use may create a vulnerability to depressive episodes — particularly upon cessation, when the withdrawal-induced low mood can be severe enough to meet diagnostic criteria for a depressive episode.
Vaping and Mental Health in Young People
The mental health implications of vaping are particularly significant for young people, whose neurological development is still incomplete and whose brains are more sensitive to the long-term effects of nicotine exposure on reward circuitry. Adolescent and young adult brains are in a period of significant pruning and organisation of neural pathways, and nicotine during this period can have lasting effects on the dopaminergic and serotonergic systems that regulate mood, motivation, and emotional regulation.
Research on adolescent vapers has found higher rates of anxiety and depression than in age-matched non-vaping peers, with the association remaining significant after controlling for pre-existing mental health status. This means the association is not entirely explained by young people with mental health conditions being more likely to vape — there appears to be a direction of effect from vaping to mental health deterioration in this population that is concerning from a public health perspective.
The HPRA and Health Research Board have both identified the mental health context of adolescent vaping as a priority area for research and policy attention in Ireland. Young vapers who experience worsening anxiety or mood changes should discuss these experiences with their GP, who can assess the degree to which nicotine dependence may be contributing to their mental health presentation and advise on appropriate support.
What Happens to Mental Health When Vapers Reduce or Stop
For vapers considering reducing their nicotine intake or stopping entirely, the mental health dimension is one of the most practically important to prepare for. Nicotine withdrawal includes anxiety, irritability, difficulty concentrating, depressed mood, and sleep disruption among its documented symptoms, and these symptoms peak in the first one to three days following cessation before gradually resolving over two to four weeks.
For vapers with pre-existing anxiety or depression, these withdrawal symptoms can temporarily worsen their underlying condition during the cessation period, which is one of the reasons that many people who attempt to stop nicotine use make their most serious attempts during periods of relative stability rather than crisis. Discussing nicotine reduction plans with a GP or mental health professional allows appropriate support to be in place during the most vulnerable period.
The medium-term mental health outcomes of nicotine cessation are generally positive for most people. Meta-analyses of studies examining anxiety and depression before and after cessation consistently find that, once the withdrawal period is past, ex-users report lower anxiety, improved mood, and better emotional regulation than they experienced as nicotine users. This counterintuitive finding is consistent with the model that describes much of nicotine-related “stress relief” as relief from withdrawal-induced anxiety rather than genuine stress reduction below baseline.
Practical Approaches for Vapers Managing Mental Health
For vapers who are also managing anxiety or depression, several evidence-consistent approaches help navigate the interaction between their nicotine use and their mental health.
Stabilising nicotine levels — rather than allowing large swings between adequate and depleted states — reduces the mood-disrupting effects of the dependency cycle. This means using nicotine consistently throughout the day rather than going long periods without it followed by heavy use, and addressing the overnight gap with a slow-release product if overnight withdrawal symptoms are affecting mood in the morning. Consistent levels produce more stable mood than the peaks and troughs of irregular use.
Addressing underlying anxiety or depression through evidence-based means that are independent of nicotine creates the foundation for eventually reducing nicotine dependence from a stronger position. Cognitive behavioural therapy, which has strong evidence for both anxiety and depression, and which also has applications in nicotine dependence management, is available in Ireland through the HSE, through GP referral, and through private practitioners. For vapers who use nicotine primarily as a self-medication strategy for mental health symptoms, addressing the mental health condition directly is the most effective path to both improved wellbeing and reduced nicotine dependence.
